Harte-Hanks (HHS) Reports Q2 Loss of $0.04
Tweet
Share
E-mailGet Alerts HHS Hot Sheet
Price: $4.30 +53.02%
Financial Fact:
Production and distribution: 27.28M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Production and distribution: 27.28M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Harte-Hanks (NYSE: HHS) reported Q2 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $94.7 million, versus $97.3 million reported last year.
For earnings history and earnings-related data on Harte-Hanks (HHS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
- LeonaBio (LONA) Reiterated at Market Outperform by Citizens on Pipeline Development
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
